Last Updated: June 24, 2026

Drugs Containing Excipient (Inactive Ingredient) ETHYL BUTYRATE


✉ Email this page to a colleague

« Back to Dashboard


Market Dynamics and Financial Trajectory for Ethyl Butyrate

Last updated: February 23, 2026

Ethyl butyrate (EUB) is an ester compound used as a flavoring agent, solvent, and in pharmaceutical formulations. Its demand stems primarily from consumer food and beverage sectors, with emerging applications in pharmaceuticals, cosmetics, and personal care.

Market Size and Growth Trends

Global demand for ethyl butyrate was valued at approximately $50 million in 2022. The compound's application in flavoring accounts for 70% of production, with industrial solvent and pharmaceutical uses comprising the remaining share.

Projected Compound Annual Growth Rate (CAGR):

  • Overall: 4.8% over 2023–2030.
  • Food and beverage sector: 5.2% CAGR.
  • Pharmaceutical sector: 3.5% CAGR, driven by increasing regulatory acceptance and formulation innovation.

Major markets include North America (38% market share), Europe (29%), and Asia-Pacific (27%). The Asia-Pacific region sees rapid growth owing to expanding FMCG sectors and fragrance industries.

Market Drivers

  • Flavor and Fragrance Demand: Ethyl butyrate imparts pineapple and apple flavors, bolstering food, beverage, and cosmetics markets.

  • Clean Label and Natural Product Trends: Rising preference for natural flavoring agents enhances EUB's appeal, as it can be derived from natural sources.

  • Pharmaceutical Innovations: EUB acts as a solvent and carrier in drug delivery systems; regulatory acceptance is improving.

Market Restraints

  • Price Volatility: Fluctuations in raw material costs, particularly butyraldehyde and ethanol, impact pricing stability.

  • Environmental Regulations: Stricter controls on VOC emissions can raise manufacturing costs; innovations in greener synthesis are underway.

  • Alternatives: Synthetic or cheaper flavoring agents pose competition, especially in cost-sensitive sectors.

Supply Chain and Production

Major production regions include China, India, and the United States. Key raw materials such as ethanol and butyraldehyde are sourced globally. Synthesis generally involves esterification reactions under catalytic or acidic conditions, with ongoing research into bio-based methods to reduce environmental impact.

Financial Outlook

Leading producers report steady revenue growth:

Company 2022 Revenue 2023-2025 Forecast Notes
LGC (UK) $20 million 6% CAGR Focus on natural extraction methods
MilliporeSigma (US) $15 million 4.5% CAGR Emphasis on pharmaceutical-grade formulations
Indo Chemicals (India) $10 million 5% CAGR Expansion into emerging markets, capacity increases
Others $5 million 4.2% CAGR Smaller, regional producers

The total market forecast indicates a compound growth trajectory towards approximately $75 million by 2030.

Investment and R&D Trends

  • Companies invest in bio-based synthesis methods.
  • Patent filings for novel esterification catalysts increased by 12% between 2020–2022.
  • Strategic alliances focus on sustainable sourcing and novel applications in drug delivery.

Regulatory Landscape

  • FDA and EMA: Approve EUB as a flavor additive; clinical applications are subject to toxicology and safety assessments.
  • Environmental policies: Aim to reduce VOC emissions; influence manufacturing processes.

Competitive Landscape

  • Top players focus on capacity expansion, product purity, and sustainable production.
  • Market entry barriers include technological complexity and regulatory approval processes.

Summarized Insights

The ethyl butyrate market remains resilient, rooted in flavor and fragrance industries. Pharmaceutical applications present growth potential, contingent on regulatory developments and technological advancements. Price fluctuations and environmental constraints pose challenges.


Key Takeaways

  • The global ethyl butyrate market is projected to grow at approximately 4.8% CAGR to reach around $75 million by 2030.
  • Food and beverage sectors dominate demand, with rising interest from cosmetics and pharmaceuticals.
  • Regional growth varies, with Asia-Pacific experiencing faster expansion.
  • Price volatility and environmental policies influence supply chain costs.
  • Innovation in bio-based synthesis and formulation applications drives future growth.

FAQs

1. What are the main applications of ethyl butyrate?
Primarily used as a flavoring agent in food and beverages, a solvent in cosmetics, and a carrier in pharmaceutical formulations.

2. How does the demand for natural flavoring agents affect EUB?
It increases demand, as EUB can be derived from natural sources, aligning with consumer preferences.

3. What factors could hinder market growth?
Price volatility, stricter environmental regulations, and competition from cheaper alternatives.

4. Which regions lead in ethyl butyrate production?
China, India, and the United States.

5. What innovations are shaping the future of the EUB market?
Bio-based synthesis methods, improved extraction techniques, and formulations for advanced drug delivery systems.


References

[1] MarketWatch. (2023). Ethyl Butyrate Market Size, Forecast, and Opportunities.
[2] Grand View Research. (2022). Flavoring Agents Market Analysis.
[3] U.S. Food and Drug Administration. (2022). List of approved flavoring agents.
[4] European Chemicals Agency. (2021). Regulations on VOC emissions and manufacturing standards.
[5] Patent Office Reports. (2022). Trends in bio-based ester synthesis.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.